Thomas R. Bauer Jr.
Staff Scientist
Center for Cancer Research
National Cancer Institute
United States of America
Biography
Born in Southwestern PA, but raised during my formative years in the suburbs of Los Angeles, I left SoCal for Indiana, where I received a B.S. in microbiology from the University of Notre Dame in 1985. Desiring warmer weather, I went to the University of Miami (Florida), where I received a Ph.D. in microbiology and immunology in 1992 studying human immunoglobulin lambda light chain genes. From there, I joined the laboratory of Dennis Hickstein in Seattle, where I was a postdoc and later acting instructor, working on LAD and CD18, and to my current position as staff scientist at the NCI.
Research Interest
leukocyte adhesion deficiency (LAD); canine leukocyte adhesion deficiency (CLAD); gene transfer; leukocytes
Publications
-
Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. Molecular Therapy. 2013 May 31;21(5):964-72.
-
Donahue RE, Tuschong L, Bauer TR, Yau YY, Leitman SF, Hickstein DD. Leukocyte integrin activation mediates transient neutropenia after G-CSF administration. Blood. 2011 Oct 13;118(15):4209-14.
-
Hunter MJ, Zhao H, Tuschong LM, Bauer Jr TR, Burkholder TH, Persons DA, Hickstein DD. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters. Human gene therapy. 2011 Jan 26;22(6):689-96.
-
Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. Molecular Therapy. 2013 May 31;21(5):964-72.
